A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Clinical trial NCT07647029 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07647029
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)

Start date: 2026-05-28
Primary completion: 2028-02-29
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.